Dachaigh › Tumor Wilms
Sgrùdaidhean clionaigeach Tumor Wilms a’ fastadh anns na SA
Tha 17 sgrùdaidhean airson Tumor Wilms a’ fastadh phàirtichean aig làraichean air feadh nan Stàitean Aonaichte.
Bailtean leis na sgrùdaidhean as motha
- Washington, DC7 sgrùdaidhean
- Memphis, TN6 sgrùdaidhean
- Atlanta, GA5 sgrùdaidhean
- New York City, NY4 sgrùdaidhean
- Cincinnati, OH4 sgrùdaidhean
- Chicago, IL4 sgrùdaidhean
- St. Louis, MO4 sgrùdaidhean
- Boston, MA4 sgrùdaidhean
- Mountain View, CA4 sgrùdaidhean
- Los Angeles, CA4 sgrùdaidhean
- Greenburgh, NY4 sgrùdaidhean
- Houston, TX4 sgrùdaidhean
- Philadelphia, PA4 sgrùdaidhean
- Aurora, CO4 sgrùdaidhean
- Minneapolis, MN4 sgrùdaidhean
- Ann Arbor, MI3 sgrùdaidhean
- Birmingham, AL3 sgrùdaidhean
Le stàit
- Alabama3 sgrùdaidhean
- California5 sgrùdaidhean
- Colorado4 sgrùdaidhean
- Florida3 sgrùdaidhean
- Georgia5 sgrùdaidhean
- Illinois4 sgrùdaidhean
- Massachusetts4 sgrùdaidhean
- Michigan3 sgrùdaidhean
- Minnesota5 sgrùdaidhean
- Missouri4 sgrùdaidhean
- New York6 sgrùdaidhean
- Ohio5 sgrùdaidhean
- Pennsylvania4 sgrùdaidhean
- Sgìre Cholumbia7 sgrùdaidhean
- Tennessee6 sgrùdaidhean
- Texas6 sgrùdaidhean
Sgrùdaidhean air an ùrachadh o chionn ghoirid
Teacsa sgrùdaidh oifigeil (Beurla)
Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor
A’ fastadhÌre 2
Aoisean 12 gu 39 · Gach gnè · Air ùrachadh 29 Sult 2026 · NCT04616560Biomarkers of Resiliency In Childhood Cancer Surgery
A’ fastadhSgrùdadh amharc
Aoisean 3 gu 25 · Gach gnè · Air ùrachadh 14 Sult 2026 · NCT06674811A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
A’ fastadhÌre 2
Suas gu aois 30 · Gach gnè · Air ùrachadh 25 Lùna 2026 · NCT04322318Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
A’ fastadhÌre 1/2
12 Months – 30 Years · Gach gnè · Air ùrachadh 25 Lùna 2026 · NCT04851119Selective Antigen Specific T Cells and CAR T Cells in Subjects With Relapsed/Refractory Embryonal Tumors (SABRE)
A’ fastadhÌre 1
Aoisean 1 gu 23 · Gach gnè · Air ùrachadh 13 Lùna 2026 · NCT07172958Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors
A’ fastadhÌre 1
Aoisean 1 gu 21 · Gach gnè · Air ùrachadh 6 Lùna 2026 · NCT04715191Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors
A’ fastadhÌre 1/2
6 Months – 25 Years · Gach gnè · Air ùrachadh 30 Ògmh 2026 · NCT06625190B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)
A’ fastadhÌre 1
Suas gu aois 21 · Gach gnè · Air ùrachadh 19 Cèit 2026 · NCT04897321Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma
A’ fastadhÌre 1/2
12 Months – 30 Years · Gach gnè · Air ùrachadh 19 Cèit 2026 · NCT04901702A Study of Selinexor in People With Wilms Tumors and Other Solid Tumors
A’ fastadhÌre 2
12 Months · Gach gnè · Air ùrachadh 6 Cèit 2026 · NCT05985161Treatment of Newly Diagnosed Patient's With Wilm's Tumor Requiring Abdominal Radiation Delivered With Proton Beam Irradiation
A’ fastadhÌre 2
Gach aois · Gach gnè · Air ùrachadh 23 Gibl 2026 · NCT04968990Vorinostat in Combination With Chemotherapy in Relapsed/Refractory Solid Tumors and CNS Malignancies
A’ fastadhÌre 1
Aoisean 1 gu 30 · Gach gnè · Air ùrachadh 15 Gibl 2026 · NCT04308330Pencil Beam Scanning in Patients With Renal Tumors
A’ fastadhÌre 1 tràth
Aoisean 0 gu 30 · Gach gnè · Air ùrachadh 15 Gibl 2026 · NCT03810651Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor T Cells
A’ fastadhÌre 1
Aoisean 1 gu 26 · Gach gnè · Air ùrachadh 17 Gearr 2026 · NCT07148050Immunotherapy For Adults With GPC3-Positive Solid Tumors Using IL-15 and IL-21 Armored GPC3-CAR T Cells
A’ fastadhÌre 1
Suas gu aois 21 · Gach gnè · Air ùrachadh 3 Samh 2025 · NCT06198296A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors
A’ fastadhÌre 2
18 Months – 40 Years · Gach gnè · Air ùrachadh 12 Lùna 2025 · NCT05135975International PPB/DICER1 Registry
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
0 Minutes – 100 Years · Gach gnè · Air ùrachadh 30 Faoi 2025 · NCT03382158Bho ClinicalTrials.gov, dàta air a thogail 5 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.